Jefferies Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.5M Sell
361,688
-139,240
-28% -$16.1M 0.3% 53
2025
Q4
$52.7M Buy
500,928
+277,608
+124% +$26.1M 0.27% 65
2025
Q3
$18.7M Buy
223,320
+90,832
+69% +$7.48M 0.09% 156
2025
Q2
$10.5M Sell
132,488
-2,431
-2% -$193K 0.09% 162
2025
Q1
$12.1M Sell
134,919
-172,362
-56% -$16.1M 0.11% 131
2024
Q4
$30.6M Buy
307,281
+161,426
+111% +$16.6M 0.18% 89
2024
Q3
$16.6M Buy
145,855
+36,835
+34% +$4.38M 0.12% 110
2024
Q2
$13.5M Sell
109,020
-118,379
-52% -$15.2M 0.14% 108
2024
Q1
$30M Buy
227,399
+54,501
+32% +$6.72M 0.28% 56
2023
Q4
$18.8M Buy
172,898
+58,930
+52% +$6.12M 0.12% 113
2023
Q3
$11.7M Buy
113,968
+106,270
+1,380% +$11.5M 0.11% 147
2023
Q2
$888K Buy
7,698
+3,550
+86% +$403K 0.01% 962
2023
Q1
$441K Sell
4,148
-29,755
-88% -$3.21M ﹤0.01% 1128
2022
Q4
$3.76M Buy
+33,903
New +$3.47M 0.03% 468

Other funds holding MRK

Jefferies Financial Group's MRK Position: Q1 2026 in Review

Jefferies Financial Group reduced its Merck (MRK) stake by 28% in Q1 2026, selling an estimated $16.1M and leaving 361,688 shares worth $43.5M. The position accounts for 0.3% of the portfolio, ranked #53.

Jefferies Financial Group first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $52.7M in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jefferies Financial Group held 361,688 shares of Merck worth $43.5M as of Q1 2026.
  • Jefferies Financial Group sold 139,240 Merck shares in Q1 2026, an estimated $16.1M.
  • Merck made up 0.3% of Jefferies Financial Group's portfolio in Q1 2026, its #53 holding.
  • Jefferies Financial Group first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Merck position peaked at $52.7M in Q4 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.